InMed Pharmaceuticals Inc. (INM): Total Liabilities
$1.96M
As of 2026-06-30
-1.0%
3-year compound annual growth
-4.1%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $1.96M | -8.9% | 2026-09-09, Balance as of period end |
| 2025-06-30 | $2.15M | -18.0% | 2026-09-09, Balance as of period end |
| 2024-06-30 | $2.62M | +29.8% | 2025-09-23, Balance as of period end |
| 2023-06-30 | $2.02M | -45.6% | 2024-09-30, Balance as of period end |
| 2022-06-30 | $3.71M | +54.2% | 2023-09-29, Balance as of period end |
| 2021-06-30 | $2.40M | +25.0% | 2022-09-23, Balance as of period end |
| 2020-06-30 | $1.92M | n/a | 2021-09-24, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | 2026-06-30 | $1.96M | -8.9% |
| Hepion Pharmaceuticals, Inc. (HEPA) | 2025-12-31 | $402.4K | -88.4% |
| Alaunos Therapeutics, Inc. (TCRT) | 2025-12-31 | $813.0K | +17.5% |
| Avenue Therapeutics, Inc. (ATXI) | 2025-12-31 | $1.10M | +34.7% |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | $20.33M | +127.9% |
| Palatin Technologies Inc (PTN) | 2025-06-30 | $8.04M | -25.9% |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $672.0K | +14.3% |
| Artelo Biosciences, Inc. (ARTL) | 2025-12-31 | $4.07M | +121.2% |
| Protagenic Therapeutics, Inc.\new (PTIX) | 2026-03-31 | $1.03M | -79.5% |
Compare INM, HEPA, TCRT, ATXI side by side · Screen every company in Pharmaceutical Preparations ↗